CYBERDYNE : Consolidated Financial Results (Tanshin) for the Three Months Ended June 30, 2022 (Based on IFRS)

Consolidated Financial Results (Tanshin)

for the Three Months Ended June 30, 2022 (Based on IFRS)

August 12, 2022

Name of listed company

:CYBERDYNE, INC.

Stock exchange listing

:Mothers Section of TSE

Stock code

:7779

URL

:https://www.cyberdyne.jp/english

Representative (title)

:President and CEO

Name

:Yoshiyuki Sankai

Contact (title)

:Director and CFO

Name

:Shinji Uga

Tel. [phone]

Scheduled date for release of three-month report

:August 12, 2022

Scheduled start of dividend payment

:－

Additional materials for the financial results

:None

Information meeting for the financial results

:None

(Millions of yen: Rounded to the nearest one million yen)

Ⅰ. Consolidated financial results for the three months ended June 30, 2022 (April 1, 2022-June 30, 2022)

1. Consolidated result of operations

(percentages denote year-on-year change)

Revenue

Operating profit

Profit (loss) before tax

Profit (loss) attributable to

(loss)

owners of parent

%

%

%

%

Apr.1-June 30, 2022

751

97.6

(174)

－

376

－

244

－

Apr.1-June 30, 2021

380

5.9

(283)

－

(265)

－

(276)

－

Basic earnings (loss)

Diluted earnings (loss)

per share

per share

Yen

Yen

Apr.1-June 30, 2022

1.13

1.13

Apr.1-June 30, 2021

(1.28)

(1.28)

2. Consolidated financial position

Total assets

Total equity

Total equity attributable to

Ratio of equity attributable

owners of the parent

to owners of the parent to

total assets

Millions of yen

Millions of yen

Millions of yen

%

As of June 30, 2022

50,583

43,853

43,816

86.6

As of March 31, 2022

49,459

43,457

43,419

87.8

Ⅱ. Dividends

Dividend payments for each term and the year

End of

End of

End of

Fiscal year end

1st quarter

2nd quarter

3rd quarter

Total

(March.31)

(June.30)

(September.30)

(December.31)

Fiscal year ended

Yen

Yen

Yen

Yen

Yen

－

0.00

－

0.00

0.00

March 31, 2022

Fiscal year ending

－

March 31, 2023

Notes:

(ⅰ) Changes from the latest released dividend forecasts: none

(ⅱ) The table of "Dividends" indicates dividend payments on Common Shares. Dividends on Class Share (non-listed) for which the number of share units differs from Common Shares are shown below as "Dividends on Class Shares".

Ⅲ. Forecast of consolidated financial results for the fiscal year ending March 31, 2022 (April 1, 2021-March 31, 2022)

As the business of CYBERDYNE Inc. and its group companies (collectively referred to as the "Group") is based on a new market with innovative technologies, there are many uncertain factors that could have an impact on its performance and make it difficult for CYBERDYNE Inc. (the "Company") to provide a forecast with accurate figures. As such the Company will not announce the forecast of consolidated financial results.

Notes:

1. Changes in key subsidiaries during the consolidated three month period (changes in specific subsidiaries resulting in

changes of consolidation scope): none
new: － (company name: － ) ,	excluded: － (company name: － )

2. Changes in accounting policies, accounting estimates, and restatement of error corrections (ⅰ) Changes in accounting policies required by IFRS : none

(ⅱ) Changes in accounting policies due to reasons other than (ⅰ) : none

(ⅲ) Changes in accounting estimates: none

3. Total number of issued shares (Common Shares)

(ⅰ) Total number of issued shares at the end of each period (including treasury shares)

	As of June 30, 2022	215,145,809	shares	As of March 31, 2022	215,145,809	shares
(ⅱ) Total number of treasury shares at the end of each period
	As of June 30, 2022	11,671	shares	As of March 31, 2022	11,671	shares
(ⅲ) Average number of shares during each three month period
	Apr.1-June 30, 2022	215,134,138	shares	Apr.1-June 30, 2021	215,137,038	shares

Note: Class B Shares are ranked the same as Common Shares and paid the same amount as Common Shares with regard to dividends of surplus and distribution of residual assets. Therefore the total number of issued shares at each end of period and the average number of shares during each period include Class B Shares as Common Shares.

*This quarterly consolidated financial report is not subject to the quarterly review procedure by the scope of audit.

Dividends on Class Shares

Details of dividends on the Company's class shares for which the number of share units differs from its Common Shares are as below.

		Dividend payments for each term and the year
	End of	End of	End of	Fiscal year end
	1st quarter	2nd quarter	3rd quarter	Total
	(March.31)
	(June.30)	(September.30)	(December.31)
Fiscal year ended	Yen	Yen	Yen	Yen	Yen
－	0.00	－	0.00	0.00
March 31, 2022
Fiscal year ending	－
March 31, 2023

Note:

The Company issued Class B Shares which were accorded the same rights as its Common Shares with regard to dividends and distribution of residual assets, but for which share units differ from Common Shares.

○ Contents of the Attached Material
1. Qualitative information regarding the settlement of accounts for the three months.……………………………………………	2
(1) Explanation of operating results.……………………………………………………………………………………………	2
(2) Explanation of financial position……………………………………………………………………………………………	5
(3) Status of cash flow..…………………………………………………………………………………………………………	6
2. Condensed quarterly consolidated financial statement (Unaudited) …………………………………………………………	7
(1) Condensed quarterly consolidated statement of financial position (Unaudited)……………………………………………	7
(2) Condensed quarterly consolidated statement of profit or loss and condensed quarterly consolidated statement of	9
comprehensive income (Unaudited)...………………………………………………………………………………………
Condensed year to quarter end consolidated statement of profit or loss……………………………………………………	9
Condensed year to quarter end consolidated statement of comprehensive income...………………………………………	10
(3) Condensed quarterly consolidated statement of changes in equity (Unaudited)……………………………………………	11
(4) Condensed quarterly consolidated statement of cash flows (Unaudited)...…………………………………………………	13
(5) Notes to condensed quarterly consolidated financial statements……………………………………………………………	14
(Notes on premise of going concern) ………………………………………………………………………………………	14
(Changes in accounting policy) .……………………………………………………………………………………………	14
(Revenue) ..…………………………………………………………………………………………………………………	15

- 1 -

1. Qualitative information regarding the settlement of accounts for the three months ended June 30, 2021

(1) Explanation of operating result

All forward-looking statements included in this explanation were determined reasonable by CYBERDYNE Inc. (the "Company") and its group companies (collectively referred to as the "Group") based on currently available information for the consolidated three months ended June 30, 2022, and certain assumptions made by the Group.

The Group aims to transform society and industry by creating a Cybernics Industry. This new industry will follow the robotics and IT industries by realizing a "Techno-peer Support Society" where human and technology works together and supports each other by innovation that leaves no one behind. To be precise, the Group will make full use of Cybernics (fusion of Human, Robots, AI, and Information Systems), a new field that integrates "Human" and "Cyber/Physical Space.

Healthy Future Society using Cybernics

The Group is developing various Cybernics Technologies that accumulate, analyze, and AI processes Human Big Data (human-related physiological, psychological, lifestyle, behavioral, and environmental information) with its IoH/IoT (Internet of Humans and Things) system. The technology can also improve, regenerate, expand, and support the wearer's physical functions. Furthermore, the Group equips communication functions to all Cybernics Technologies. They are seamlessly connected to hospitals, nursing homes, homes, and workplaces through IoH/IoT by linking data and services via cloud systems. Using Cybernics Technologies, the Group will challenge cultivating a "healthy future society" where people can participate in society with a high level of independence and health, even if they experience multiple disuses, disease, or disability. The Group will promote Society 5.0/5.1 as a healthy and sustainable society through this challenge.

Status of business development

<> (Japan)

The Group continues its efforts to establish Cybernic Treatment, a treatment program using Medical HAL systems that aims to induce improvement and regeneration of the functions of the brain, nerves, and muscles into a global standard of treatment. Post-marketing surveillance on the Medical HAL Lower Limb Type Double-leg Model suggested a high efficacy and safety towards progressive neuromuscular diseases. As a result of the proposal, the revision of insurance pricing for 2022 allows hospitals that use the DPC system (80% of base hospitals treating intractable diseases in Japan) to calculate insurance for treatment with HAL for hospitalized patients. Also, insurance reimbursement pricing associated with the treatment was increased, encouraging the Group to spread the technology in the country. The Group will also utilize the result of post- marketing surveillance to list Cybernics Treatment for insurance worldwide to establish this new treatment technology as a global standard for progressive neuromuscular disease, as there were no effective treatment methods globally for these diseases before HAL.

Furthermore, regarding the investigator-initiated clinical trial for stroke patients in Japan, the primary endpoints' clinical significance and statistical significance, which are considered the most crucial evaluation points of this clinical trial, are being discussed with the authorities and investigators, and statistical experts. The Group also considers the result as compelling data for medical insurance for stroke worldwide.

In addition, the University of Tsukuba Hospital started clinical trials to investigate the effect of HAL on improving the physical functions of children affected by cerebral palsy on January 2022.

- 2 -